These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9146772)

  • 1. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis.
    Lucidarme D; Marteau P; Foucault M; Vautrin B; Filoche B
    Aliment Pharmacol Ther; 1997 Apr; 11(2):335-40. PubMed ID: 9146772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens.
    Farup PG; Hovde O; Halvorsen FA; Raknerud N; Brodin U
    Scand J Gastroenterol; 1995 Feb; 30(2):164-70. PubMed ID: 7732340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis.
    Gionchetti P; Rizzello F; Venturi A; Brignola C; Ferretti M; Peruzzo S; Campieri M
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1053-7. PubMed ID: 9663829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of mesalazine slow release suppositories 1 g three times per week to maintain remission of ulcerative proctitis: a randomised double blind placebo controlled multicentre study.
    Marteau P; Crand J; Foucault M; Rambaud JC
    Gut; 1998 Feb; 42(2):195-9. PubMed ID: 9536943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Management of Ulcerative Proctitis: When and How to Use Mesalazine Suppository.
    Kato S; Ishibashi A; Kani K; Yakabi K
    Digestion; 2018; 97(1):59-63. PubMed ID: 29393142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Kruis W; Neshta V; Pesegova M; Alekseeva O; Andreev P; Datsenko O; Levchenko O; Abdulkhakov S; Lozynskyy Y; Mostovoy Y; Soloviev K; Dorofeyev AE; Vieth M; Stiess M; Greinwald R; Mohrbacher R; Siegmund B
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):98-106.e4. PubMed ID: 29702300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation -- a placebo-controlled study.
    Watanabe M; Nishino H; Sameshima Y; Ota A; Nakamura S; Hibi T
    Aliment Pharmacol Ther; 2013 Aug; 38(3):264-73. PubMed ID: 23734840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].
    Ngô Y; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial.
    Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L
    Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative, open, randomized trial of the efficacy and tolerance of slow-release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis: French Pentasa Study Group.
    Marteau P; Florent C
    Am J Gastroenterol; 2000 Jan; 95(1):166-70. PubMed ID: 10638577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].
    Ngô Y; Gélinet JM; Ivanovic A; Kac J; Schénowitz G; Vilotte J; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(10):782-6. PubMed ID: 1478406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
    Andus T; Kocjan A; Müser M; Baranovsky A; Mikhailova TL; Zvyagintseva TD; Dorofeyev AE; Lozynskyy YS; Cascorbi I; Stolte M; Vieth M; Dilger K; Mohrbacher R; Greinwald R;
    Inflamm Bowel Dis; 2010 Nov; 16(11):1947-56. PubMed ID: 20310020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis.
    Yamamoto T; Shimoyama T; Matsumoto K
    Aliment Pharmacol Ther; 2015 Sep; 42(5):549-58. PubMed ID: 26140337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mesalamine 1 g HS versus 500 mg BID suppositories in mild to moderate ulcerative proctitis: a multicenter randomized study.
    Lamet M; Ptak T; Dallaire C; Shah U; Grace M; Spenard J; de Montigny D;
    Inflamm Bowel Dis; 2005 Jul; 11(7):625-30. PubMed ID: 15973115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance treatment of ulcerative proctitis with mesalazine suppositories: a double-blind placebo-controlled trial. The Italian IBD Study Group.
    d'Albasio G; Paoluzi P; Campieri M; Bianchi Porro G; Pera A; Prantera C; Sturniolo GC; Miglioli M
    Am J Gastroenterol; 1998 May; 93(5):799-803. PubMed ID: 9625131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The usefulness of mesalazine suppositories for the treatment of lymphoid follicular proctitis].
    Seo GS; Choi SC; Jo EY; Choi CS; Kim JW; Kim TH; Yun KJ; Nah YH
    Korean J Gastroenterol; 2006 Jun; 47(6):420-4. PubMed ID: 16809948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis.
    Seo EH; Kim TO; Kim TG; Joo HR; Park J; Park SH; Yang SY; Moon YS; Park MJ; Ryu DY; Song GA
    Dig Dis Sci; 2011 Sep; 56(9):2672-7. PubMed ID: 21365239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis.
    Gionchetti P; Rizzello F; Venturi A; Ferretti M; Brignola C; Miglioli M; Campieri M
    Dis Colon Rectum; 1998 Jan; 41(1):93-7. PubMed ID: 9510317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis.
    van Hogezand RA; van Hees PA; van Gorp JP; van Lier HJ; Bakker JH; Wesseling P; van Haelst UJ; van Tongeren JH
    Aliment Pharmacol Ther; 1988 Feb; 2(1):33-40. PubMed ID: 2979230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.